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Summary
 
Engagement of antigen receptors on mature B lymphocytes is known to block cell entry into
lymphoid follicles and promote accumulation in T cell zones, yet the molecular basis for this
change in cell distribution is not understood. Previous studies have shown that follicular exclu-
sion requires a threshold level of antigen receptor engagement combined with occupancy of
follicles by B cells without equivalent receptor engagement. The possibility has been raised that
follicular composition affects B cell positioning by altering the amount of available antigen and
the degree of receptor occupancy. Here we show that follicular composition affects migration
of mature B cells under conditions that are independent of antigen receptor occupancy. B cells
deficient in the negative regulatory protein tyrosine phosphatase, SHP1, which have elevated
intracellular signaling by the B cell receptor, are shown to accumulate in the T zone in the ab-
sence of their specific antigen. Follicular exclusion of SHP1–deficient B cells was found to be
conditional on the presence of excess B cells that lack elevated intracellular signaling, and was
not due to a failure of SHP-1–deficient cells to mature and express the follicle-homing
chemokine receptor Burkitt’s lymphoma receptor 1. These findings strongly suggest that signals
that are negatively regulated by SHP1 promote B cell localization in T cell zones by reducing
competitiveness for follicular entry, and provide further evidence that follicular composition
influences the positioning of antigen-engaged B cells.
 
M
 
ature recirculating B cells that have entered second-
ary lymphoid tissues pass rapidly through the outer T
cell zone and migrate into B cell follicles (1). In contrast,
mature B cells that have bound antigen are blocked from
migrating into lymphoid follicles and, in most cases, take
up temporary residence in the outer T cell zone (2, 3). B
cells that have encountered a foreign antigen may present
MHC–peptide complexes to antigen-specific T cells and be
induced to differentiate into antibody-secreting cells or
into germinal center cells. Studies in Ig-transgenic models
have established that autoantigen-binding B cells can also
be excluded from follicles and retained in the outer T zone
(4, 5). In this case, T cell help may not be available due to
T cell tolerance mechanisms and the autoreactive B cells
undergo rapid cell death. Together, these studies indicate
that retention of B cells in the outer T zone may be impor-
tant both for promoting immune responses to foreign anti-
gens and for purging cells with specificity for self-antigens.
The mechanisms controlling whether a B cell migrates
into a follicle or localizes in the T zone are poorly defined.
Immature B cells that have left the bone marrow and en-
tered the spleen do not migrate directly into lymphoid fol-
licles but appear both in the red pulp and T zone (6). This
may reflect a developmentally regulated property such as
the absence of the orphan chemokine receptor, Burkitt’s
lymphoma receptor 1 (BLR1), on immature B cells (refer-
ence 7 and this manuscript). BLR1 is primarily expressed
on mature B cells and is necessary for mature B cell homing
into splenic follicles (8).
In B cells that have matured to express BLR1, additional
factors regulate localization in outer T zones versus folli-
cles, and these have been examined in most detail in the
anti–hen egg lysozyme (HEL)
 
1
 
 Ig transgenic/HEL trans-
genic model (9). Based on studies in this system, two mod-
els of follicular exclusion have been proposed: a competi-
tion-dependent model (4) and a cell-intrinsic model (10).
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Abbreviations used in this paper:
 
 BLR1, Burkitt’s lymphoma receptor 1;
CFSE, carboxyfluorescein diacetate succinimidyl ester; HEL, hen egg
lysozyme; MBP, mannose-binding protein; 
 
me
 
v
 
, motheaten viable; Rag,
recombination-activating gene.
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Signaling and Competition in B Cell Follicular Homing
 
In the competition-dependent model, B cell antigen recep-
tor engagement by soluble HEL is necessary but not suffi-
cient to mediate follicular exclusion, and competitior B
cells that are not binding equivalent amounts of HEL anti-
gen must also be present (4, 11). In the cell-intrinsic model,
antigen receptor engagement alone is sufficient to mediate
follicular exclusion (10, 12). A criticism of the studies indi-
cating a role for competitor B cells has been that the exper-
iments that altered the amount of competition, by chang-
ing the total frequency of HEL-binding cells, also may have
altered the amount of HEL antigen. Although differences
in antigen concentration or receptor occupancy have not
been reproducibly detected in mice with different numbers
of HEL-binding B cells (12–14), it remains possible that
there are local differences in the way HEL antigen is pre-
sented within the secondary lymphoid tissues. Distinguish-
ing between these models is important for understanding
how autoreactive B cells are regulated in the periphery and
for considering whether the increased frequency of autoim-
munity observed in immunodeficient individuals could be a
consequence of insufficient interclonal competition (15).
To explore whether mature B cells influence each
other’s positioning in a system that is independent of possi-
ble local effects on antigen presentation, we have examined
the localization of SHP1-deficient B cells in mice contain-
ing or lacking wild-type B cells. SHP1 is an SH2-contain-
ing cytosolic protein tyrosine phosphatase (PTPase) that is
widely expressed in the hematopoietic system (16). A nega-
tive regulatory function for this PTPase in B lymphocyte
antigen receptor signaling was identified by studying B cells
from motheaten viable (
 
me
 
v
 
) mice, which carry a mutation
in SHP1 that reduces activity to 20% of wild-type levels
(17–19). In the course of studies on Ig-transgenic 
 
me
 
v
 
 mice,
it was observed that many SHP1-deficient B cells develop-
ing in the absence of antigen downregulated their surface
IgM, increased MHC class II expression, and had twofold
lower CD21 as they matured to an IgD
 
hi
 
 conventional B
cell phenotype (19). This altered pattern of receptor ex-
pression mirrors that of wild-type Ig-transgenic B cells de-
veloping in the presence of the weak self-antigen soluble
HEL (13, 19), in which continued B cell receptor engage-
ment and chronic calcium and extracellular signal regulated
kinase (ERK) signals occur (20). These observations sug-
gest that SHP1-deficient B cells have an elevated level of
basal antigen receptor signaling in the absence of antigen
(21). In this report we show that SHP1 regulates the signal-
ing pathways that mediate exclusion of mature B cells from
lymphoid follicles. We also find that positioning of SHP1-
deficient B cells is influenced by the presence or absence of
wild-type B cells.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) Ig-transgenic mice were of the MD4
line, which carries transgenes encoding IgM
 
a
 
 and IgD
 
a
 
 heavy
chains and a light chain that pair to form a high affinity anti-HEL
specificity (9). B6 HEL-transgenic mice were of the ML5 line,
 
which carries a transgene encoding HEL under the metallothio-
nein promoter, and contained HEL at 
 
z
 
1 nM in serum (9). B6 
 
me
 
v
 
/
 
1
 
 mice (Jackson Laboratories, Bar Harbor, ME) were mated with
B6 MD4 Ig-transgenic mice and with bcl2-22–transgenic mice
(22; more than six generations backcross to B6). 
 
me
 
v
 
/
 
1
 
 Ig/bcl2
double transgenic mice were then mated with 
 
me
 
v
 
/
 
1
 
 nontrans-
genic littermates. B6 recombination-activating gene (Rag)1
 
2
 
/
 
2
 
mice (23) and B6 
 
m
 
2
 
/
 
2
 
 mice (24) were obtained from Jackson
Laboratories.
 
Chimeric Mice.
 
Lymphoid tissues were isolated as previously
described (9). 
 
me
 
v
 
/me
 
v
 
 Ig-transgenic, 
 
me
 
v
 
/me
 
v
 
 Ig/bcl2 double
transgenic, and control donors were killed at 4–7 wk of age and
bone marrow was mixed with nontransgenic wild-type, Rag1
 
2
 
/
 
2
 
,
or 
 
m
 
2
 
/
 
2
 
 bone marrow at the ratio stated in the Results section
and 3–5 
 
3
 
 10
 
6
 
 cells were injected into the lateral tail vein of B6
recipients that had been lethally irradiated with two doses of 450
rads X-irradiation separated by 3 h. The animals received antibi-
otics (polymixin B, 110 mg/liter, and neomycin 1.1 g/liter) in
the drinking water for the whole 5-8–wk reconstitution period
until analysis. After reconstitution, animals were killed, the spleen
removed, three fourths of the organ was frozen in OCT com-
pound (Miles Inc., Elkhart, IN) for sectioning. Cell suspensions
were prepared from the remainder, counted, and analyzed by
flow cytometry.
 
Adoptive Transfers.
 
Donor cells isolated from the spleen of
nontransgenic B6 mice were labeled with 5- (and 6-) carboxyflu-
orescein diacetate succinimidyl ester (CFSE; Molecular Probes,
Eugene, OR) as described (25). Bone marrow chimeric mice 7–8
wk after reconstitution were injected in the lateral tail vein with
0.3-ml aliquots of labeled spleen cells containing 10
 
7
 
 B cells. After
1 d, the spleen was removed and used for flow cytometry and mi-
croscopy.
 
Preparation of Anti-BLR1 Antiserum.
 
Sequence encoding amino
acids 20–57 of mouse BLR1 (26) was isolated by reverse tran-
scriptase PCR and introduced into the pGEX-2T (27) and
pMAL-p2 (New England Biolabs, Beverly, MA) vectors. Glu-
tathione-
 
S
 
-transferase (GST) and mannose-binding protein (MBP)
fusion proteins were affinity purified and the GST fusion was
used for immunization of rabbits following standard procedures
(Josman Laboratories, Napa, CA). Serum from one rabbit showed
reactivity with the MBP–BLR1 fusion protein by Western blot-
ting and BLR1-specific antibodies were affinity purified by pas-
sage over a column of MBP–BLR1 covalently coupled to Sepharose
CL4B (Pharmacia, Piscataway, NJ). Staining of cells with the an-
tiserum was revealed with goat anti–rabbit FITC (Caltag, Burlin-
game, CA). The antiserum was found to specifically stain BLR1,
but not vector control, transfected 293 cells (data not shown).
 
Immunohistochemistry and Immunofluorescence Microscopy.
 
Cryostat
sections (7 mm) were fixed and stained as previously described
(14). In immunohistochemistry, HEL-binding cells were detected
by incubating with HyHEL9-biotin followed by avidin-conju-
gated alkaline phosphatase (Sigma Chemical Co., St. Louis, MO);
mAbs specific for B220 (6B2), or CD4 and CD8 (Caltag) were
rat IgG antibodies and were detected with goat anti-rat–conju-
gated horseradish peroxidase (Southern Biotechnical Associates,
Birmingham, AL). Enzyme reactions were developed with con-
ventional substrates for peroxidases (diaminobenzidine/H
 
2
 
O
 
2
 
)
and alkaline phosphatase (FAST RED/Napthol AS-MX). Sec-
tions were counterstained in hematoxylin and mounted in crystal
mount (Biomeda Corp., Foster City, CA). For immunofluores-
cence microscopy, HEL-binding cells were detected by incubat-
ing with HyHEL9-biotin followed by streptavidin-conjugated 
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Cy-3 (Jackson Immunoresearch, West Grove, PA) and marginal
metallophilic macrophages were identified with MOMA-1 (28)
followed by goat anti-rat–conjugated aminomethylcoumarin (Jack-
son Immunoresearch). Sections were mounted in a 50% glycerol/
PBS mixture and viewed with a fluorescence microscope (DMRL;
Leica, Wetzlar, Germany). Images were acquired on a video camera
(Optronics MDEI850 cooled CCD, Optronics Engineering, Go-
leta, CA) and were processed with Photoshop software (Adobe
Systems Inc., Mountain View, CA).
 
Results
 
B Cells with Exaggerated Signaling Due to Deficiency of
SHP1 Are Spontaneously Excluded from Lymphoid Follicles.
 
Normal B cell development is inhibited in 
 
me
 
v
 
 mice by
trans effects of dysregulated myeloid cells (29–31). How-
ever, when bone marrow from 
 
me
 
v
 
/me
 
v
 
 mice and from
wild-type mice is mixed in a 20:80 ratio and used to recon-
stitute lethally irradiated wild-type recipients, development
of immature B cells is restored and small numbers of ma-
ture SHP1-deficient B cells are detectable in the periphery
(19). To test the follicular homing properties of SHP1-
deficient B cells, mixed bone marrow chimeric mice were
constructed with a 20:80 mixture of bone marrow from
 
me
 
v
 
/me
 
v
 
 Ig-transgenic mice and wild-type nontransgenic
mice. Using bone marrow from SHP1-deficient mice car-
rying the anti-HEL Ig transgenes allowed the SHP1-defi-
cient B cells to be distinguished from the wild-type B cells.
In preliminary experiments, we observed that the 
 
me
 
v
 
/me
 
v
 
Ig-transgenic bone marrow contributed 
 
,
 
1% of the spleen
cells in these animals (Fig. 1, 
 
C
 
 and 
 
D
 
), whereas in mice re-
constituted with 20% wild-type Ig-transgenic bone mar-
row, 2–8% of spleen cells were Ig transgenic (Fig. 1, 
 
A
 
 and
 
B
 
). To generate control mice producing a comparable
number of wild-type Ig-transgenic cells to the 
 
me
 
v
 
 chime-
ras, mixed chimeras were constructed with 5% Ig-trans-
genic and 95% nontransgenic bone marrow. After allowing
6 wk for reconstitution of the hematopoietic system,
spleens were isolated from the chimeric animals, a small
fraction was stained and examined by flow cytometry to
measure the frequency of HEL-binding cells, and the re-
mainder was used to prepare sections for immunohis-
tochemistry. 
Wild-type B cells carrying the anti-HEL specificity and
developing in mice lacking HEL were able to migrate into
lymphoid follicles and become evenly dispersed among the
diverse population of nontransgenic B cells (Fig. 2 
 
A
 
). In
contrast, SHP1-deficient B cells did not become evenly
dispersed through follicles, but were distributed predomi-
nantly in the T cell zone and marginal zone bridging chan-
nels (Fig. 2 
 
B
 
). The marked retention of SHP1-deficient B
cells in the T cell zone was also clearly seen in sections
stained to detect T cells and HEL-binding cells (Fig. 2 
 
D
 
)
and enumeration of the HEL-binding B cells within splenic
white pulp cords established that 60% of SHP1-deficient B
cells localized in regions costained for CD4 and CD8 com-
pared with only 10% of wild-type cells (Fig. 3). Anti-HEL
antibody secreting plasma cells were also detected in the
red pulp of 
 
me
 
v
 
/me
 
v
 
–wild-type chimeric animals, but these
were readily distinguished from HEL-binding B cells by
their larger size and very intense cytoplasmic staining with
HEL (data not shown). In some of the chimeras peanut ag-
glutinin (PNA)-positive germinal centers were identified
within splenic follicles (Fig. 2 
 
F
 
) and SHP1-deficient HEL-
binding B cells were sometimes localized within these ger-
minal centers (Fig. 2 
 
E
 
). However, even in these cases, the
 
me
 
v
 
 B cells remained excluded from the surrounding mantle
of resting B cells.
Figure 1. Frequency of immature and mature mev/mev or 1/1 Ig-
transgenic B cells in bone marrow chimeric mice containing and lacking
wild-type nontransgenic B cells. (A–J) Two-color flow cytometric analy-
sis of bone marrow and spleen cell suspensions to detect the transgenic a
alleles of IgM and IgD. B cells derived from nontransgenic bone marrow
express the b alleles of IgM and IgD and are not stained. The 20:80 bone
marrow mixture used to reconstitute each mouse is shown to the left of
the flow cytometric profiles. Adjacent panels show staining of bone mar-
row and spleen cells from a single bone marrow chimeric animal. Num-
bers in each panel refer to the percent of total cells within the gated re-
gion. The bone marrow data is representative of at least two animals of
each type. Numbers shown in the right panels correspond to the mean
(1/2 standard deviation) percentage of cells for several (n) animals. 
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Follicular Exclusion of SHP1-deficient B Cells Is Not Rescued
by Introduction of a bcl2 Transgene.
 
To test whether the failure
of 
 
me
 
v
 
 B cells to localize efficiently in lymphoid follicles was
secondary to failure of the cells to survive, 
 
me
 
v
 
 mice were
crossed with bcl2–transgenic mice (22), and 
 
me
 
v
 
/me
 
v
 
-Ig/
bcl2 transgenic bone marrow was used for the construction
of chimeras at a ratio of 20% 
 
me
 
v
 
/me
 
v
 
-Ig/bcl2–transgenic
bone marrow and 80% wild-type nontransgenic bone mar-
row. Control chimeras were established using 2% wild-
type Ig/bcl2-transgenic bone marrow and 98% nontrans-
genic bone marrow. Cells from the spleens of chimeric
mice reconstituted for 5–6 wk were stained to determine
the frequency of HEL-binding B cells. Constitutive expres-
sion of the bcl2 transgene in SHP1-deficient B cells led to
an approximately fivefold increase in the number of these
cells in the spleen (Fig. 1 
 
F
 
). When cell localization was ex-
amined, the exclusion of me
 
v
 
 B cells from follicles and ac-
cumulation in the T cell zone was even more marked than
in the case of cells lacking the bcl2 transgene (Fig. 2 
 
H 
 
and
Fig. 3). The distribution of cells in control Ig/bcl2 chimeras
did not differ notably from their distribution in the absence
of the bcl2 transgene (Fig. 2 
 
G
 
). This strongly suggests that
the failure of SHP1-deficient B cells to accumulate in lym-
phoid follicles is not secondary to cell death. Conversely,
the higher frequency of SHP1-deficient Ig/bcl2-transgenic
B cells in the T zone than in the case of cells lacking the
bcl2 transgene suggests that many 
 
me
 
v
 
/me
 
v
 
 B cells normally
reach the T zone but undergo rapid cell death.
 
SHP1-deficient B Cells Localize in Lymphoid Follicles when
Wild-type B Cells Are Lacking.
 
Having observed antigen-
independent exclusion of SHP1-deficient B cells from lym-
phoid follicles, we went on to ask whether the exclusion of
these cells was dependent on competition between SHP1-
deficient and wild-type B cells. This required assessing
whether SHP1-deficient B cells localized in follicles or re-
 
mained distributed in the T zone when wild-type B cells
were lacking. For this purpose, we established mixed bone
marrow chimeras using 20% 
 
me
 
v
 
/me
 
v
 
 Ig-transgenic bone
marrow (or wild-type marrow in controls) and 80%
Rag1
 
2
 
/
 
2
 
 bone marrow. Since Rag1
 
2
 
/
 
2
 
 bone marrow
should contribute normally to the myeloid compartment,
we expected that the effects of 
 
mev/mev-derived myeloid
cells would continue to be diluted by wild-type (Rag12/2)
myeloid cells. However, no mature B cells would be gen-
erated from Rag12/2 bone marrow, and hence, no wild-
type B cells should be produced to compete with SHP1-
deficient B cells in the periphery. Flow cytometric analysis
of bone marrow from mev/mev–Ig:Rag12/2 chimeras estab-
lished that immature SHP1-deficient B cells could develop
in these animals (Fig. 1 I) and mature B cells with an IgDhi
conventional phenotype were detected in the periphery
(Fig. 1 J). As in previous chimeras, many of the SHP1-defi-
cient B cells in the periphery had downregulated IgM (Fig.
1 J). Strikingly, in the absence of competing normal B cells,
the SHP1-deficient B cells in the spleens of these chimeric
mice displayed a follicular distribution very similar to the
distribution of wild-type cells in control chimeras (Fig. 4,
A and B).
To further test whether SHP1-deficient B cells in mev/
mev:Rag12/2 chimeras were located in follicles, we trans-
ferred fluorescently (CFSE) labeled wild-type B cells into
several chimeric animals 1 d before tissue isolation. By trans-
ferring small numbers of wild-type B cells and providing
only sufficient time for these cells to home normally to fol-
licles, we minimized the possibility that the transferred cells
would induce changes in the distribution of the endoge-
nous SHP1-deficient B cells. After 16 h, the transferred
wild-type B cells were present in the spleen in similar
numbers to the endogenous SHP1-deficient B cells and
were found intermingled with these cells (Fig. 4 C) con-
firming that the SHP1-deficient B cells were organized in
follicles. The presence of MOMA-1–positive marginal
zone macrophages at the border of the B cell clusters (Fig.
4 C, blue staining) also established their authenticity as folli-
cles (28). To exclude the possibility that SHP1-deficient B
cells no longer located in the T cell zone because of a pau-
city of wild-type T cells in the mev/mev–Rag12/2 chimeras,
a further set of chimeras were constructed using a mixture
of bone marrow from mev/mev-Ig–transgenic mice and
mice with a disruption of the IgM (m) heavy chain, which
fail to produce B cells (24). Since T cell development is not
disrupted in m2/2 animals, T cell production in these chi-
meras is expected to be identical to that in mev/mev:1/1
mixed bone marrow chimeras. Small numbers of CFSE-
Figure 2. Exclusion of SHP1-deficient B cells from primary follicles and mantle zones of secondary follicles in mice containing wild-type B cells.
Spleen sections from chimeric mice stained in red to detect Ig-transgenic cells (A–E, G, and H) and in brown to detect B220 (A, B, and E–H), or CD4
and CD8 (C and D). In F, a serial section to that in E is shown stained with peanut agglutinin (red) to detect germinal centers. A and C show distribution
of 1/1 Ig-transgenic B cells; B, D, and E show distribution of mev/mev Ig-transgenic B cells, G shows distribution of 1/1 Ig/bcl2 double transgenic B
cells, and H shows the distribution of mev/mev-Ig/bcl2 double transgenic B cells. Spleens are from nontransgenic mice reconstituted for 6 wk with mix-
tures of the following bone marrow: A and C, 5% 1/1 Ig-transgenic and 95% nontransgenic; B, and D–F, 20% mev/mev-Ig–transgenic and 80% non-
transgenic; G, 2% 1/1 Ig/bcl2 double transgenic and 98% nontransgenic; H, 20% mev/mev-Ig/bcl2 double transgenic and 80% nontransgenic. f, follicle;
t, T cell zone. Original magnification: A, B, and E–H, 310 objective; C and D, 320 objective. The figures are representative of tissue sections from the
following number of chimeric mice: A and C, six mice; B and D, nine mice; E and F, three mice; G, two mice; and H, three mice.
Figure 3. Percentage of Ig-
transgenic B cells within the
splenic white pulp that are lo-
cated in the T cell zone. Cells
were enumerated in sections
from two mice double stained
for T cell markers CD4 and CD8
and HEL-binding cells. All the
HEL-binding cells present in the
white pulp cord of each splenic
cross-section were counted and
cross-sections of white pulp cords
were counted until a minimum
of 100 HEL-binding cells had
been counted for each spleen.934 Signaling and Competition in B Cell Follicular Homing
labeled wild-type spleen cells were also transferred into
these chimeras 16 h before analysis. Again, SHP1-deficient
B cells were found to organize into follicles rather than lo-
cating within the T cell zone (Fig. 4 D).
SHP1-deficient B Cells Express BLR1. Studies in BLR1
knockout mice have established an important role for this
orphan chemokine receptor in B cell homing to splenic
follicles (8). To examine whether the exclusion of SHP1-
deficient B cells from lymphoid follicles could reflect a fail-
ure to express BLR1, spleen cells from chimeric mice were
stained with an affinity purified antiserum specific for the
NH2 terminus of BLR1. SHP1-deficient cells were found
to express high levels of surface BLR1 (Fig. 5) and levels were
similar in mice that contained competitor cells, where the
SHP1-deficient cells were excluded from follicles, and in
animals that lacked competitor cells where the SHP1-defi-
cient cells were follicular (data not shown). Immature
(IgM1IgDlo/2) B cells by contrast expressed little or no
BLR1 (Fig. 5).
Discussion
The findings above allow us to reach two conclusions:
(a) SHP1 regulates intracellular signals controlling B cell
positioning and (b) B cells can influence each others posi-
tioning through a process that cannot be explained by vari-
ation in antigen availability or presentation. These findings
provide strong support for the model that at least two fac-
Figure 4. Follicular localization of mev B cells in mice deficient in wild-type B cells. (A and B) Spleen sections from chimeric mice stained to detect Ig-
transgenic cells (red) and CD4 and CD8 T cells (brown). (C and D) Spleen sections from chimeric mice that 16 h earlier received CFSE-labeled wild-type
spleen cells. HEL-binding cells are stained red, MOMA-1–positive macrophages are stained blue, and transferred CFSE-labeled cells are detected as green
cells. Mice had been reconstituted 6 wk earlier with: (A) 20% 1/1 Ig-transgenic and 80% Rag12/2 bone marrow, (B and C) 20% mev/mev Ig-transgenic
and 80% Rag12/2 bone marrow, and (D) 20% mev/mev Ig-transgenic and 80% m2/2 bone marrow. A is representative of two and B of seven mice. C and
D are each representative of two mice. Original magnification: A and B, 310 objective; C and D, 320 objective.935 Schmidt et al.
tors contribute to the follicular exclusion of mature B cells:
intracellular signaling by the BCR and the presence or ab-
sence of competitor B cells without equivalent levels of in-
tracellular signaling.
SHP-1 deficiency could cause B cells to be excluded
from follicles in competitive circumstances by exaggerating
signals from the BCR that oppose follicular tropism, or by
interfering with delivery of maturation signals that promote
follicular migration. Studies by MacLennan and coworkers
have established that when immature B cells first enter the
spleen, they are unable to migrate into follicles and instead
locate in the outer T zone and in the red pulp (6, 32).
What regulates the transition from an immature cell newly
arrived in the periphery to a mature recirculating cell is
poorly characterized and it is unclear whether the transition
requires a positive signal, is limited by negative signals, or
both. It seems likely that competency to enter follicles and
become a recirculating cell relates at least in part to expres-
sion of BLR1, since this receptor is required for B cell en-
try into splenic follicles and it is not expressed on immature
B cells (Fig. 4 and references 7, 26). Although it is conceiv-
able that SHP1 deficiency interrupts B cell entry into folli-
cles by inhibiting B cell maturation, we think this possibil-
ity is unlikely since the majority of SHP1-deficient B cells
in the spleen express high levels of IgD and BLR1. Fur-
thermore, immature syk2/2 B cells do not enter follicles
even when mature B cells are lacking (32), whereas the
SHP1-deficient cells localize within follicles in the absence
of wild-type competitor B cells.
The distribution of SHP1-deficient B cells in the pres-
ence of competitor B cells is not identical to the distribu-
tion of antigen-engaged wild-type B cells (11). Although
the latter cells tend to accumulate at the border of B and T
cell zones, SHP1-deficient cells were more frequently dis-
persed through the T zone or located in marginal zone
bridging channels between T zone and red pulp. Although
some cells were also present in the red pulp, these are likely
to be immature cells newly arriving in the spleen from the
bone marrow. Overall, the distribution of cells in the white
pulp cords is similar to antigen-binding B cells that also are
receiving T cell help (11, 33) and suggests that in addition
to downregulating signaling by the antigen receptor, SHP1
may also negatively regulate one or more pathways nor-
mally stimulated upon encounter with antigen-specific T
cells. This is also suggested by the finding of anti-HEL anti-
body secreting plasma cells and HEL-binding germinal
center cells in some of the chimeric animals. The failure of
mev B cells to accumulate in normal numbers as mature B
cells in the periphery, even when containing a constitu-
tively expressed bcl2 transgene or in mice lacking competi-
tor cells, also suggests increased activation of intracellular
pathways leading to cell death.
SHP1-mediated negative regulation of antigen-receptor
signaling involves recruitment of the phosphatase to intra-
cellular tyrosine-based inhibitory motifs (ITIMs) in the cy-
toplasmic domain of CD22 (34). The evidence that SHP1
plays a role in setting the basal level of antigen receptor sig-
naling within B cells has recently been extended by the
finding that mature B cells deficient in CD22, like SHP1-
deficient B cells, have downmodulated surface IgM and in-
creased class II and CD44 expression in the absence of
added antigen (for review see reference 35). These findings
support the notion that SHP1-deficient B cells have ele-
vated basal signaling from the antigen receptor. The possi-
bility that SHP1 regulates intracellular signaling pathways
in B cells in addition to the antigen receptor has gained
support from the finding of a family of molecules expressed
in mature B cells that contain ITIMs. These molecules,
which include the paired Ig-like receptors (PIRs; reference
36), leukocyte Ig-like receptor (LIR-1; reference 37), leu-
kocyte-associated Ig-like receptor 1 (LAIR-1; reference
38), and Ig-like transcript 2 (ILT2; reference 39) are ho-
mologous to both the killer-inhibitory receptor (KIR) fam-
ily of negative regulatory molecules expressed on natural
killer cells and to CD22, and therefore are likely to act as
negative regulators although the nature of their function is
undefined. It will be important in future studies to deter-
mine the predominant molecules that recruit SHP1 in B
cells and to characterize substrates of SHP1. Such studies
should help define the signaling pathways that regulate ex-
pression of BLR1 and other molecules that function to
control the localization and survival of mature B cells.
In summary, the findings reported here provide evidence
that exclusion of mature B cells from follicles and accumu-
Figure 5. BLR1 expression on SHP1-deficient and wild-type B cells.
(Top) BLR1 expression on IgM1IgDlo/2 bone marrow B cells (immature)
and IgM1IgD1 spleen B cells (mature) from a 1/1 Ig-transgenic mouse.
(Bottom) BLR1 expression on B2201 HEL-binding SHP1-deficient
spleen cells from a mouse reconstituted 6 wk earlier with 20% mev/mev Ig-
transgenic and 80% Rag12/2 bone marrow. The dotted line (control)
shows staining with an irrelevant rabbit antiserum (top) or anti-BLR1
staining of T cells (bottom) as controls.936 Signaling and Competition in B Cell Follicular Homing
lation in the T cell zone is, in the absence of antigen, con-
ditional on both elevated intracellular signaling and the
presence of competitor B cells without such exaggerated
signaling. Since interclonal competition among peripheral
B cells may play a major role in determining the composi-
tion of the long-lived follicular B cell population (15), fur-
ther efforts to understand the mechanism of competition
are needed. In particular it will be important to define
whether chemokine gradients are involved in positioning B
cells in follicles or T zones and how these might be affected
by follicular composition.
Many thanks to R. Cornall, K. Reif, and A. Weiss for helpful discussions.
K.N. Schmidt is a recipient of a Deutsche Forschungsgemeinschaft postdoctoral fellowship. J.G. Cyster is a
Pew Scholar and C.C. Goodnow was supported by the Howard Hughes Medical Institute. This work was
supported in part by a grant from the National Institutes of Health (AI-40098-01A1) to J.G. Cyster.
Address correspondence to Jason Cyster, Department of Microbiology and Immunology, Box 0414, Uni-
versity of California at San Francisco, San Francisco, CA 94143. Phone: 415-502-6427; Fax: 415-502-8424;
E-mail: cyster@itsa.ucsf.edu
The present address of C.C. Goodnow is Medical Genome Centre & Australian Cancer Research Founda-
tion Genetics Laboratory, John Curtin School of Medical Research, PO Box 334, Mills Rd., The Australian
National University, Canberra, ACT 2601, Australia.
Received for publication 19 November 1997 and in revised form 15 January 1998.
References
1. Nieuwenhuis, P., and W.L. Ford. 1976. Comparative migra-
tion of B- and T-lymphocytes in the rat spleen and lymph
nodes. Cell. Immunol. 23:254–267.
2. Liu, Y.-J., J. Zhang, P.J.L. Lane, E.Y.-T. Chan, and I.C.M.
MacLennan. 1991. Sites of specific B cell activation in pri-
mary and secondary responses to T cell–dependent and T
cell–independent antigens. Eur. J. Immunol. 21:2951–2962.
3. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of
the primary immune response to (4-hydroxy-3-nitrophenyl)
acetyl. I. The architecture and dynamics of responding cell
populations. J. Exp. Med. 173:1165–1175.
4. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Com-
petition for follicular niches excludes self-reactive cells from
the recirculating B-cell repertoire. Nature. 371:389–395.
5. Mandik-Nayak, L., A. Bui, H. Noorchashm, A. Eaton, and J.
Erikson. 1997. Regulation of anti–double-stranded DNA B
cells in nonautoimmune mice: localization to the T–B inter-
face of the splenic follicle. J. Exp. Med. 186:1257–1267.
6. Lortran, J.E., C.A. Roobottom, S. Oldfield, and I.C.M.
MacLennan. 1987. Newly produced virgin B cells migrate to
secondary lymphoid organs but their capacity to enter folli-
cles is restricted. Eur. J. Immunol. 17:1311–1316.
7. Forster, R., T. Emrich, E. Kremmer, and M. Lipp. 1994. Ex-
pression of the G-protein–coupled receptor BLR1 defines
mature, recirculating B cells and a subset of T-helper mem-
ory cells. Blood. 84:830–840.
8. Forster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and
M. Lipp. 1996. A putative chemokine receptor, BLR1, di-
rects B cell migration to defined lymphoid organs and specific
anatomic compartments of the spleen. Cell. 87:1–20.
9. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J.
Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wother-
spoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immu-
noglobulin expression and functional silencing of self-reactive
B lymphocytes in transgenic mice. Nature. 334:676–682.
10. Fulcher, D.A., and A. Basten. 1994. Reduced life span of an-
ergic self-reactive B cells in a double-transgenic model. J.
Exp. Med. 179:125–134.
11. Cyster, J.G., and C.C. Goodnow. 1995. Antigen-induced
exclusion from follicles and anergy are separate and comple-
mentary processes that influence peripheral B cell fate. Immu-
nity. 3:691–701.
12. Cooke, M.C., A. Basten, and B. Fazekas de St. Groth. 1997.
Outer periarteriolar lymphoid sheath arrest and subsequent
differentiation of both naive and tolerant immunoglobulin
transgenic B cells is determined by B cell receptor occupancy.
J. Exp. Med. 186:631–643.
13. Goodnow, C.C., J. Crosbie, H. Jorgensen, R.A. Brink, and
A. Basten. 1989. Induction of self-tolerance in mature pe-
ripheral B lymphocytes. Nature. 342:385–391.
14. Mason, D.Y., M. Jones, and C.C. Goodnow. 1992. Devel-
opment and follicular localization of tolerant B lymphocytes
in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int.
Immunol.  4:163–175.
15. Goodnow, C.C., J.G. Cyster, S.B. Hartley, S.E. Bell, M.P.
Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue,
and K.P. Shokat. 1995. Self-tolerance checkpoints in B lym-
phocyte development. Adv. Immunol. 59:279–368.
16. Tonks, N.K., and B.G. Neel. 1996. From form to function:
signaling by protein tyrosine phosphatases. Cell. 87:365–368.
17. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle,
R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Muta-
tions at the murine motheaten locus are within the hemato-
poietic cell protein-tyrosine phosphatase (Hcph) gene. Cell.
73:1445–1454.
18. Tsui, H.W., K.A. Siminovitch, L. de Souza, and F.W. Tsui.
1993. Motheaten and viable motheaten mice have mutations
in the haematopoietic cell phosphatase gene. Nat. Genet. 4:
124–129.
19. Cyster, J.G., and C.C. Goodnow. 1995. Protein tyrosine937 Schmidt et al.
phosphatase 1C negatively regulates antigen receptor signal-
ing in B lymphocytes and determines thresholds for negative
selection. Immunity. 2:13–24.
20. Healy, J.I., R.E. Dolmetsch, L.A. Timmerman, J.G. Cyster,
M.L. Thomas, G.R. Crabtree, R.S. Lewis, and C.C. Good-
now. 1997. Different nuclear signals are activated by the B
cell receptor during positive versus negative signaling. Immu-
nity. 6:419–428.
21. Cyster, J.G. 1997. Signaling thresholds and interclonal com-
petition in preimmune B cell selection. Immunol. Rev. 156:
87–101.
22. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M.
Adams, S. Cory, and A.W. Harris. 1991. Enforced bcl2 ex-
pression in B-lymphoid cells prolongs antibody responses and
elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88:
8661–8665.
23. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S.
Tonegawa, and V.E. Papaioannou. 1992. Rag-1 deficient
mice have no mature B and T lymphocytes. Cell. 68:869–877.
24. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A
B cell–deficient mouse by targeted disruption of the mem-
brane exon of the immunoglobulin m chain gene. Nature.
350:423–426.
25. Lyons, A.B., and C.R. Parish. 1994. Determination of lym-
phocyte division by flow cytometry. J. Immunol. Methods.
171:131–137.
26. Kaiser, E., R. Forster, I. Wolf, C. Ebensperger, W.M. Kuehl,
and M. Lipp. 1993. The G-protein coupled receptor BLR1 is
involved in murine B cell differentiation and is also expressed
in neuronal tissues. Eur. J. Immunol. 23:2532–2539.
27. Smith, D.B., and K.S. Johnson. 1988. Single-step purification
of polypeptides expressed in Escherichia coli as fusions with
glutathione S-transferase. Gene. 67:31–40.
28. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int.
Rev. Cytol. 132:31–73.
29. Medlock, E.S., I. Goldschneider, D.L. Greiner, and L.
Shultz. 1987. Defective lymphopoiesis in the bone marrow of
motheaten (me/me) and viable motheaten (mev/mev) mutant
mice. II. Description of a microenvironmental defect for the
generation of terminal deoxynucleotidyltransferase-positive
bone marrow cells in vitro. J. Immunol. 138:3590–3597.
30. Hayashi, S., P.L. Witte, L.D. Shultz, and P.W. Kincade.
1988. Lymphohemopoiesis in culture is prevented by interac-
tion with adherent bone marrow cells from mutant viable
motheaten mice. J. Immunol. 140:2139–2147.
31. Shultz, L.D. 1991. Hematopoiesis and models of immunode-
ficiency. Semin. Immunol. 3:397–408.
32. Turner, M., A. Gulbranson-Judge, M.E. Quinn, A.E.
Walters, I.C.M. MacLennan, and V.L.J. Tybulewicz. 1997.
Syk tyrosine kinase is required for the positive selection of
immature B cells into the recirculating B cell pool. J. Exp.
Med. 186:2013–2022.
33. Fulcher, D.A., A.B. Lyons, S.L. Korn, M.C. Cook, C.
Koleda, C. Parish, B. Fazekas de St. Groth, and A. Basten.
1996. The fate of self-reactive B cells depends primarily on
the degree of antigen receptor engagement and availability of
T cell help. J. Exp. Med. 183:2329–2336.
34. Doody, G.M., L.B. Justement, C.C. Delibrias, R.J. Mat-
thews, J. Lin, M.L. Thomas, and D.T. Fearon. 1995. A role
in B cell activation for CD22 and the protein tyrosine phos-
phatase SHP. Science. 269:242–244.
35. Cyster, J.G., and C.C. Goodnow. 1997. Tuning antigen re-
ceptor signaling by CD22: integrating cues from antigens and
the microenvironment. Immunity. 6:509–517.
36. Kubagawa, H., P.D. Burrows, and M.D. Cooper. 1997. A
novel pair of immunoglobulin-like receptors expressed by B
cells and myeloid cells. Proc. Natl. Acad. Sci. USA. 94:5261–
5266.
37. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L.
Peterson, and M.L. Hsu. 1997. A novel immunoglobulin su-
perfamily receptor for cellular and viral MHC class I mole-
cules. Immunity. 7:273–282.
38. Meyaard, L., G.J. Adema, C. Chang, E. Woollatt, G.R.
Sutherland, L.L. Lanier, and J.H. Phillips. 1997. LAIR-1, a
novel inhibitory receptor expressed on human mononuclear
leukocytes. Immunity. 7:283–290.
39. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J.
Samaridis, L. Angman, M. Cellan, and M. Lopez-Botet.
1997. A common inhibitory receptor for major histocompat-
ability complex class I molecules on human lymphoid and
myelomonocytic cells. J. Exp. Med. 186:1809–1818.